Placebo-controlled, double-blind, exploratory study of KW-6002 (istradefylline) in the treatment of Parkinson's disease [adjunctive therapy to levodopa]
Phase of Trial: Phase II
Latest Information Update: 07 Feb 2017
At a glance
- Drugs Istradefylline (Primary)
- Indications Parkinson's disease
- Focus Therapeutic Use
- 20 Jul 2006 New trial record.